HCA Holdings Inc (NYSE:HCA). reported a stronger-than-expected performance for the fourth quarter of 2024, with earnings per share (EPS) surpassing analyst forecasts. Despite this, the company's stock experienced a decline in pre-market trading,

My name is Janine, and I will be your conference operator for today. At this time, I would like to welcome everyone to the HCA Healthcare fourth quarter 2024 earnings call. All lines have been placed on mute to prevent any background noise.

HCA Healthcare, Inc. HCA reported fourth-quarter 2024 adjusted earnings per share (EPS) of $6.22, which outpaced the Zacks Consensus Estimate by 4.2%. The bottom line advanced 5.4% year over year. See the Zacks Earnings Calendar to stay ahead of market-making news.